Massive Multi-Ancestry Study Maps Tissue-Specific Drivers of Type 2 Diabetes
Published in Nature Metabolism, the analysis leverages data from over 2.5 million people to prioritize causal targets for future validation.
Overview
- Researchers from UMass Amherst and Helmholtz Munich led an international effort that compared seven diabetes-relevant tissues across four ancestry groups to pinpoint causal genes and proteins.
- The study identified 676 genes with causal evidence across key tissues, with only 18% detectable in blood and 85% of tissue effects absent from blood.
- Blood-only analyses implicated 335 genes and 46 proteins in type 2 diabetes risk, underscoring the limits of relying on peripheral blood data.
- The work draws on the Type 2 Diabetes Global Genomics Initiative’s GWAS resource covering more than 2.5 million participants, including over 700,000 of non-European ancestry, revealing shared and ancestry-specific signals.
- The authors emphasize that findings are computational and outline next steps that include laboratory validation, broader tissue and protein sampling beyond European cohorts, and single-cell resolution studies.